Opdivo

Active substance

Nivolumab

Holder

Bristol-Myers Squibb NV

Status

Closed

Indication

Treatment of adult patients with unresectable Malignant Pleural Mesothelioma who have progressed after at least one line of treatment including a platinum-based doublet chemotherapy.

Public documents

Approbation

Information for the patient

Informed consent

Last update

31/03/2020